| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 61.80B | 73.18B | 29.48B | 31.79B | 31.15B | 30.91B |
| Gross Profit | 32.71B | 32.38B | 29.56B | 31.79B | 31.15B | 30.91B |
| EBITDA | 12.85B | 10.56B | 10.56B | 0.00 | 14.20B | 14.00B |
| Net Income | 8.93B | 7.79B | 7.76B | 7.41B | 9.92B | 9.62B |
Balance Sheet | ||||||
| Total Assets | 1.48T | 1.46T | 1.41T | 1.41T | 1.35T | 1.18T |
| Cash, Cash Equivalents and Short-Term Investments | 8.73B | 108.10B | 108.17B | 140.83B | 119.31B | 120.05B |
| Total Debt | 255.68B | 236.69B | 300.67B | 313.81B | 310.86B | 245.66B |
| Total Liabilities | 1.39T | 1.37T | 1.33T | 1.33T | 1.27T | 1.11T |
| Stockholders Equity | 87.59B | 86.87B | 82.37B | 76.93B | 73.22B | 70.80B |
Cash Flow | ||||||
| Free Cash Flow | 5.05B | 10.14B | 15.16B | 31.28B | 16.37B | -13.27B |
| Operating Cash Flow | 5.62B | 10.49B | 15.65B | 11.47B | 16.94B | -12.81B |
| Investing Cash Flow | -67.44B | -19.00B | -7.45B | -30.04B | -11.29B | 14.70B |
| Financing Cash Flow | 60.81B | 9.18B | -8.84B | 16.71B | -4.58B | -2.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | C$119.44B | 9.41 | 14.75% | 3.07% | -3.13% | 18.22% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | C$307.04B | 13.71 | 15.37% | 2.58% | 2.13% | 25.16% | |
66 Neutral | C$68.73B | 12.62 | 12.83% | 2.64% | 7.50% | -5.28% | |
64 Neutral | C$214.35B | 13.22 | 17.26% | 3.34% | 3.07% | 144.41% | |
62 Neutral | C$115.97B | 14.70 | 10.41% | 4.32% | -3.65% | -1.73% | |
60 Neutral | C$129.26B | 13.18 | 10.47% | 3.61% | -1.30% | 20.41% |